Harpreet Singh (via Allogeneic Cell Therapies Summit)

TCR play­er Im­mat­ics com­bines with Per­cep­tive’s blank check op­er­a­tor, scoop­ing $252M and gain­ing a list­ing on Nas­daq

Per­cep­tive Ad­vi­sors’ blank check com­pa­ny has inked a deal — and it’s land­ing right in the mid­dle of a glob­al pan­dem­ic that’s roil­ing the in­dus­try. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.